Mankind Pharma Share: Revenue toh bhaga par margin mein lagi lagi! ₹1800 Cr tax ka bhi panga

HEALTHCAREBIOTECH

Overview

Arre bhaiyo, Mankind Pharma ne Q3 FY26 mein apna revenue **11.5%** badha liya hai, poora **₹3,567 Crore** ho gaya! Ye BSV acquisition ki wajah se hua hai, jisse company ki net worth bhi badhi. Lekin, ek chota sa panga hai, profit margins thode kam ho gaye hain.

📉 Aakhir kya hua numbers mein?

Mankind Pharma ne Q3 FY26 mein kamaal kar diya, consolidated revenue ₹3,567.20 Crore pe pahunch gaya, matlab 11.5% ka zabardast jump pichhle saal ke comparison mein. Aur 9 mahine (9MFY26) ki baat karein toh revenue ₹10,834.71 Crore ho gaya, jo 18.6% zyada hai! Ye sab BSV acquisition (₹13,768 Crore) ki wajah se hua hai, jisse company ki net worth bhi seedha ₹14,291.13 Crore ho gayi hai. Acquisition ke baad debt bhi manage ho gaya hai, leverage ratios improve hue hain.

😟 Lekin profits mein thodi gadbad?

Lekin asli khel toh profits mein hai. Consolidated Net Profit Margins thodi si kam hui hain, quarter mein 11.6% ho gayi jo pehle 11.8% thi. Aur 9 mahine ka figure 16.4% hai, jo pichhle saal 19.4% tha. Matlab, revenue badh raha hai par profit kam ho raha hai iss rate se. Standalone interest coverage ratio bhi 4.04x pe gir gaya hai, jo pehle 8.51x tha. Yeh thoda worrying sign hai.

🚨 Tax ka naya panga!

Aur toh aur, company ₹1,800 Crore ke income tax demand ke bhi saamne khadi hai. Company ne appeal toh daal di hai, par yeh ek bada risk ho sakta hai. Management ne iske baare mein koi khaas baat nahi kahi hai, aur analysts ke sawaal bhi disclose nahi hue hain.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.